Position in TCRX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$623,120
+$60,967 QoQ
Shares Held
616,952
+9.7% QoQ
Ownership
0.944%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TCRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GEODE CAPITAL MANAGEMENT, LLC holds $18,550,967,073 across 528 Biotechnology names. TCRX ranks #343 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,139,621 | $2,741,586,360 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,607,732 | $2,014,838,051 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,660,385 | $880,241,584 | |
| 4 | INSM |
INSMED Inc
|
4,450,389 | $727,727,608 | |
| 5 | MRNA |
Moderna, Inc.
|
9,435,132 | $479,304,705 | |
| 6 | INCY |
Incyte Corp
|
4,703,184 | $442,663,677 | |
| 7 | RPRX |
Royalty Pharma plc
|
7,869,632 | $377,506,246 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
4,918,030 | $365,212,906 |
All Filings in TCRX
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $623,120 | 616,952 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $562,153 | 562,153 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $1,033,135 | 567,657 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $821,237 | 566,371 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $1,400,824 | 1,015,090 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $2,928,301 | 963,257 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $4,847,860 | 973,466 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $5,267,918 | 900,499 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $3,285,405 | 413,779 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $2,283,296 | 391,646 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $788,321 | 307,938 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $292,227 | 116,891 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $210,928 | 100,442 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $155,685 | 100,442 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $307,040 | 100,669 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $107,247 | 34,101 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $92,845 | 33,159 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $114,394 | 25,421 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $106,635 | 12,786 | Shares | Defined | 2021-11-12 | |
| No filing history on record for this holder in this stock. | ||||||